2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid

C91H117N15O20S — CID 121386444

IUPAC2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid
SMILESCCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N1C
InChIInChI=1S/C91H117N15O20S/c1-11-12-28-72-89(124)103(7)51-77(112)95-68(48-79(114)115)85(120)101-80(55(4)5)91(126)105(9)73(46-57-24-18-14-19-25-57)86(121)99-69(45-61-33-39-64(109)40-34-61)87(122)102(6)50-76(111)94-66(42-59-29-35-62(107)36-30-59)83(118)98-67(43-60-31-37-63(108)38-32-60)84(119)97-65(41-54(2)3)82(117)100-71(81(116)93-49-75(92)110)52-127-53-78(113)96-70(44-56-22-16-13-17-23-56)88(123)106(10)74(90(125)104(72)8)47-58-26-20-15-21-27-58/h13-27,29-40,54-55,65-74,80,107-109H,11-12,28,41-53H2,1-10H3,(H2,92,110)(H,93,116)(H,94,111)(H,95,112)(H,96,113)(H,97,119)(H,98,118)(H,99,121)(H,100,117)(H,101,120)(H,114,115)/t65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,80-/m0/s1
InChIKeyXESABYAUUVZXEE-VBXXZUPXSA-N
MW1773.09 g/mol
LogP1.55
Rot. Bonds23

About 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid

2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid (PubChem CID 121386444) has the molecular formula C91H117N15O20S and a molecular weight of 1773.09 g/mol. Its IUPAC name is 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid.

Molecular Properties

Compound Name2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid
PubChem CID121386444
Molecular FormulaC91H117N15O20S
Molecular Weight1773.09 g/mol
Exact Mass1771.83
IUPAC Name2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid
SMILESCCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N1C
InChIInChI=1S/C91H117N15O20S/c1-11-12-28-72-89(124)103(7)51-77(112)95-68(48-79(114)115)85(120)101-80(55(4)5)91(126)105(9)73(46-57-24-18-14-19-25-57)86(121)99-69(45-61-33-39-64(109)40-34-61)87(122)102(6)50-76(111)94-66(42-59-29-35-62(107)36-30-59)83(118)98-67(43-60-31-37-63(108)38-32-60)84(119)97-65(41-54(2)3)82(117)100-71(81(116)93-49-75(92)110)52-127-53-78(113)96-70(44-56-22-16-13-17-23-56)88(123)106(10)74(90(125)104(72)8)47-58-26-20-15-21-27-58/h13-27,29-40,54-55,65-74,80,107-109H,11-12,28,41-53H2,1-10H3,(H2,92,110)(H,93,116)(H,94,111)(H,95,112)(H,96,113)(H,97,119)(H,98,118)(H,99,121)(H,100,117)(H,101,120)(H,114,115)/t65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,80-/m0/s1
InChIKeyXESABYAUUVZXEE-VBXXZUPXSA-N
XLogP1.55
TPSA504.53 Ų
H-Bond Donors14
H-Bond Acceptors20
Rotatable Bonds23
Heavy Atoms127
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001773.09
LogP ≤ 51.55
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1020

Analyze 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
The IUPAC name of 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid (CID 121386444) is 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid.
What is the SMILES notation for 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
The canonical SMILES for 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid is CCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N1C.
What is the InChIKey of 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
The InChIKey is XESABYAUUVZXEE-VBXXZUPXSA-N. The full InChI is InChI=1S/C91H117N15O20S/c1-11-12-28-72-89(124)103(7)51-77(112)95-68(48-79(114)115)85(120)101-80(55(4)5)91(126)105(9)73(46-57-24-18-14-19-25-57)86(121)99-69(45-61-33-39-64(109)40-34-61)87(122)102(6)50-76(111)94-66(42-59-29-35-62(107)36-30-59)83(118)98-67(43-60-31-37-63(108)38-32-60)84(119)97-65(41-54(2)3)82(117)100-71(81(116)93-49-75(92)110)52-127-53-78(113)96-70(44-56-22-16-13-17-23-56)88(123)106(10)74(90(125)104(72)8)47-58-26-20-15-21-27-58/h13-27,29-40,54-55,65-74,80,107-109H,11-12,28,41-53H2,1-10H3,(H2,92,110)(H,93,116)(H,94,111)(H,95,112)(H,96,113)(H,97,119)(H,98,118)(H,99,121)(H,100,117)(H,101,120)(H,114,115)/t65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,80-/m0/s1.
What are the key properties of 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid?
2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid has a molecular weight of 1773.09 g/mol, XLogP of 1.55, 23 rotatable bonds, 14 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5S,8S,11S,17S,20S,23S,26S,32S,35S,38S,41R)-41-[(2-amino-2-oxoethyl)carbamoyl]-5,8,23-tribenzyl-11-butyl-26,32,35-tris[(4-hydroxyphenyl)methyl]-7,10,13,22,28-pentamethyl-38-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-20-propan-2-yl-1-thia-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecazacyclodotetracont-17-yl]acetic acid is sourced from PubChem (CID 121386444), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).